Tools for Antibody-Drug Conjugate Screening and Characterization
- All day: March 22, 2018
- Event Type: Webinar
- Organized by: Karen Sorenson | LabRoots, Inc.
Published on 02nd March
Antibody drug conjugates (ADCs) represent a novel method to deliver a drug to diseased cell using the specific antigen-binding capability and internalization process. Antibodies that do not internalize efficiently will have sub-optimal therapeutic results.
Presented at the Protein and Cell Analysis Education Series Virtual Event, this webinar will introduce participants to reactive chemistries, bright and versatile fluorophores, and powerful detection platforms. They will learn how these novel technologies can advance your ADC discovery and research.
Through this event, participants will learn how to perform defined conjugation with the SiteClick™ Antibody Labeling system. They will also learn how to quickly and easily screen candidate antibodies for specific internalization.
The speaker for this event will be Chris Langsdorf, a staff scientist with Thermo Fisher Scientific. As a staff scientist at Thermo Fisher, Langsdorf has developed novel fluorescent compounds for use in characterizing disease at a cellular level, and has developed tools for the study of stem cells, apoptosis and cytotoxicity, endocytosis, innate and adaptive immunity, cell proliferation, and the cell cycle. Langsdorf received his degree in biochemistry from Oregon State University.
LabRoots will host the webinar March 22, beginning at 8 a.m. PDT. To learn more about this event, discover the continuing education credits that will be offered, or to register for free, click here.
Topics to be Covered Introduction To Antibody Conjugates Overview Of Techniques In Quantitative Pharmacology No Such Thing As A Magic Bullet: The Hidden Challenges Of ADC Discovery And Development...